The European Health Forum Gastein collates all applications and works with external evaluators to assess the applications against the selection criteria. The EHFG Board approves a shortlist of nominations which are then considered by a jury panel.

We are pleased to present you projects shortlisted for the European Health Award 2017.

Press release

Project 1: Education Against Tobacco (EAT)

Through EAT more than 1,500 medical students from 28 German, four Austrian and two Swiss medical schools educate 23,800 adolescents effectively in the classroom setting per year, educate hundreds of prospective physicians for tobacco cessation in inpatient settings and conduct the largest school-based tobacco prevention trials worldwide.

Project 2: EUropean Refugees - HUman Movement and Advisory Network (EUR-HUMAN)

EUR-HUMAN aimed to rapidly enhance Primary Health Care capacity across Europe to address refugee and migrant health needs and safeguard them from risks including minimising cross-border care risks. An evidence-based, validated approach was utilised, well-tailored to their needs and matched to available service.

Project 4: Innovative patient centred health care services – advantages of establishing a close CE network in coeliac disease patient health care (Focus IN CD)

Focus IN CD project will demonstrate the development of an innovative health service model and will gain data to develop e-learning tools for health care professionals (HCPs) and patients, to close existing knowledge gaps and to improve patient support.

Project 5: The Gen-Equip Project: Equipping European Primary Care Health Professionals to Deal with Genetics

The Gen-Equip project is a European initiative to provide free, online education in genetics to health professionals, particularly general practitioners, nurses and midwives providing primary care.  The main aim is to improve healthcare of patients who have or are at risk of a condition with an underlying genetic cause.

Project 6: The impact on maritime transport of health threats due to biological, chemical and radiological agents including communicable diseases (EU SHIPSAN ACT)

EU SHIPSAN ACT focused on the impact of maritime transport on health threats due to biological, chemical and radiological agents including communicable diseases. The project aimed to strengthen an integrated strategy and sustainable mechanisms at the EU level for safeguarding the health of travellers and crew of passenger and cargo ships, and preventing the cross-border spread of diseases to improve citizens' health security.


Jury 2017

The jury panel includes representatives of the EHFG Board, EHA Sponsors and European representatives from our four pillars: civil society, science &academia, private and public sectors.

Peter Brosch

Peter Brosch

Austrian Federal Ministry of Health and Women’s Affairs

Martin McKee

Martin McKee

London School of Hygiene & Tropical Medicine | EHFG Advisory Committee member

Terje Peetso

Terje Peetso

Head of Sector eHealth & ageing policy, DG CONNECT, European Commission

Manuel Reiberg

Manuel Reiberg

President, FOPI

Albert van der Zeijden

Albert van der Zeijden

EHFG Board member

Sponsors 2017

The Award includes prize money of 10.000 EUR and is sponsored by the Austrian Federal Ministry of Health and Women’s Affairs and FOPI, the Association of the Research & Development based Pharmaceutical Industry in Austria.

Selection criteria

Initiatives & projects must comply with the following criteria to be eligible for consideration:

  1. The initiative must already be in its implementation phase, although it does not have to be completed at the time of application.
  2. Applicants should be able to provide some initial results from their initiative.
  3. The initiative must be implemented in at least two European countries.
  4. The initiative should focus on public health or health care delivery and address an important threat to the health of the population in terms of prevention or health promotion, improving quality of care or access to care or through increased efficiency or cost-effectiveness
  5. The initiative should be innovative and/or demonstrate how it has added an innovative dimension to similar projects.
  6. The initiative should be sustainable and have the potential to be transferable to other countries.

get in touch

If you are interested in finding out more about the European Health Award, have questions about the selection process, please contact:

Josef Wenninger, MSc
E: josef.wenninger[at]ehfg.org
T: +43 662 4224 0012
M: +43 664 2444 998

EHFG News & Updates

EHFG Headquarters

EHFG Salzburg Office

VAT No. ATU44155007 Bank Data:
IBAN AT 152040400200222240 
Bank Salzburger Sparkasse
Kirchplatz, 5630 Bad Hofgastein, Austria